Explain the economic difference between trading comps and precedent transactions, and why precedents typically imply a higher multiple for the same underlying business.

How this comes up in interviews

What this lesson (and its quiz) is actually testing

A cumulative review is not a re-teaching of new material - it's where interviewers separate candidates who memorized isolated definitions from those who can chain concepts under pressure. Expect two testing styles:

  1. The "walk me through a valuation" open-ended prompt. This rewards structure: naming each methodology in the right order, correctly stating what each one solves for (EV vs. equity), and volunteering the bridge between them without being asked. Candidates who jump straight to "I'd build a DCF" without first establishing EV vs. equity value and the multiples/comps context read as narrow.

  2. Rapid-fire cross-checks between methods. "Your comps say X, your DCF says Y - which do you trust more and why?" tests whether you understand the relative-vs-intrinsic distinction and can reason about why they'd diverge (market sentiment, cyclicality, differing growth assumptions) rather than just picking a favorite.

Signals of mastery: using EV as the common denominator without prompting; correctly distinguishing control premium (precedents) from pure relative valuation (comps); citing that terminal value dominates a DCF and therefore deserves the most sensitivity; and - critically - never presenting any output as a single point estimate. A candidate who says "the DCF gives $40-46 a share, comps support $38-44, and precedents (if this were a sale) would run higher on the control premium" in one breath has demonstrated the entire module's fluency in ten seconds.

Weak candidates treat this as a vocabulary quiz ("EV/EBITDA is enterprise value over EBITDA"). Strong candidates treat it as a coherent worldview: every method is trying to answer the same question - what is this business worth - from a different angle, and the job is to triangulate, not to pick one.

Common mistakes

Common traps in cumulative review

Trap 1: Answering "walk me through a valuation" as a list instead of a narrative. Reciting "comps, precedents, DCF" without connecting them reads as memorized vocabulary, not understanding.

Say it out loud: "I'd start by deciding what I'm solving for - equity value per share, typically - then build relative valuation off comps and precedents, build an intrinsic DCF as an anchor, bridge everything to the same equity value basis, and lay the ranges out as a football field to see where they agree or disagree."

Trap 2: Conflating comps and precedents, or using the wrong one for the situation. Using trading comps to set a takeover price, or precedents to value a business that isn't being acquired.

Say it out loud: "Comps price minority, liquid trading - no control premium. Precedents price actual acquisitions, so they embed a control premium and synergy expectations. I'd use precedents if control is changing hands, comps otherwise."

Trap 3: Forgetting that P/E is the equity-level exception. Applying an EV multiple to net income, or a P/E multiple to EBITDA.

Say it out loud: "EV multiples pair with pre-financing metrics like EBITDA or EBIT because capital structure doesn't change the cash flow - it just changes who gets it. P/E is the exception because net income is already after interest expense, so it's inherently equity-level and capital-structure-specific."

Trap 4: Treating a DCF or comps output as a single number. Stating "the company is worth $4.2bn" with false precision.

Say it out loud: "Every methodology here produces a range, not a point - I'd present a football field: comps, precedents, and a sensitized DCF, then use judgment to weight them for this situation."

Trap 5: Inconsistent bridging when comparing methods. Using stale net debt for the DCF bar and current net debt for the comps bar, or a basic share count for one and diluted for another.

Say it out loud: "Every bar in the field has to cross the same bridge - same net debt, same treatment of NCI and preferred, same diluted share count computed with the treasury stock method - or the comparison is meaningless."

Trap 6: Not explaining why DCF and comps disagree when asked. Simply restating that they're different numbers instead of diagnosing the gap.

Say it out loud: "If my DCF comes in below comps, either the market is pricing more growth or margin expansion than my base case assumes, or my WACC/terminal growth are too conservative - I'd reconcile by checking my assumptions against what the implied exit multiple suggests before concluding the market is simply wrong."

Also asked as

  • Walk through, in order, how you would build a full valuation of a private company from scratch, naming every methodology from this module and what each one solves for.
  • Why does enterprise value serve as the common basis across nearly every valuation methodology, with P/E as the one notable equity-level exception?
  • Why is a DCF's terminal value the single most sensitive component of the entire valuation, and what two inputs deserve the most scrutiny as a result?
  • Your DCF and your comps analysis disagree by more than 20% at the midpoint. Describe the diagnostic process you'd run before concluding one is simply wrong.
  • A company is being prepped for both an IPO and, separately, a sponsor is exploring a take-private. Explain why the appropriate valuation anchor differs between the two situations.
  • Comps imply EV of $500-560mm and a DCF sensitivity implies EV of $540-610mm on a company with net debt of $120mm and 40mm diluted shares. Bridge both to a per-share range and state where the two methods corroborate.
  • A DCF's Gordon growth terminal value implies a 15x exit EBITDA multiple, but the comp set trades at 9x-10x today. Terminal FCF is $100mm, WACC is 9%. Identify the inconsistency, propose a fix to terminal growth, and recompute the implied multiple to confirm it now falls inside the comp range.
  • A valuation package has net debt of $600mm including $100mm of capitalized operating leases that the comp set's EBITDA does not add back, and a basic share count of 90mm ignoring 8mm of in-the-money options struck at $12 with the stock at $20. Comps of 7.5x-8.5x apply to forward EBITDA of $300mm. Recompute the correct per-share comps range after fixing both the net debt and share count errors, and quantify how much the original (uncorrected) analysis overstated or understated per-share value.
  • You are in a deal team meeting the night before a pitch. Precedents imply $2.6-2.9bn EV, comps imply $2.1-2.3bn EV, the DCF implies $2.3-2.7bn EV, and an LBO ability-to-pay analysis caps at $2.4bn EV. The target has net debt of $400mm and 100mm diluted shares. Construct the full football field on a per-share basis, explain the ordering of the bars, and give your recommended price range with reasoning for how you weighted each methodology.

Drill this topic with AI-graded practice inside IB Atlas.

Start free